University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Mass Spectrometry Facility

Jennifer Gajan

Position

Graduate Student

Email

jennifer.gajan@ucsf.edu

Education

Ph.D.	Pharmaceutical Sciences and Pharmacogenomics	2007-present	University of California San Francisco, San Francisco, CA
B.Sc.	Biochemistry	2007	University of Houston, Houston, TX

Work History

2008-Present:

Graduate Student, Mass Spectrometry Facility, Pharmaceutical Science and Pharmacogenomics, UCSF, San Francisco, CA.

Research Interests

My interest is in using mass spectrometry-based approaches to further our understanding of the activated tyrosine kinase-driven malignancy, chronic myeloid leukemia (CML). Specifically, we are using mass spectrometry to monitor global phosphorylation changes following kinase inhibitor therapy.

Select Publications

Gajan, J., Kasap, C., and Shah, NP., The mechanism of action of clinically-effective dual Abl/Aurora kinase inhibitors does not involve BCR-ABL inhibition, AACR 101st Annual Meeting (2010).

The UCSF Mass Spectrometry Facility is supported by the NIH NCRR, grant number P41RR001614, and NIGMS, grant number P41GM103481.
©2003-2010 Regents of the University of California — last modified Fri Mar 5 08:45:54 2010